08045804946
Send Inquiry
MAKENZA 160MG
8500.0 INR/Number
Product Details:
- Dosage Form Oral tablet
- Salt Composition Enzalutamide
- Indication Metastatic castration-resistant prostate cancer (mCRPC)
- Origin of Medicine India
- Life Span 24 months from manufacturing
- Pacakaging (Quantity Per Box) 28 tablets per box
- Packaging Type Box, Blister strip
- Click to View more
X
MAKENZA 160MG Price And Quantity
- 8500.0 INR/Number
- 1 Number
- Oral
- Hormone Antagonist (Androgen Receptor Inhibitor)
- White to off-white
- To be used under medical supervision
- Capsule-shaped
- Yes
- Treatment of prostate cancer in men
- Mylan
MAKENZA 160MG Product Specifications
- Advanced prostate cancer treatment
- 1 strip of 28 tablets
- Anti-cancer (antineoplastic)
- Take whole with water, do not crush or chew
- As prescribed by physician
- Oral tablet
- Adults only
- Prescription only (Rx)
- Box, Blister strip
- 28 tablets per box
- MAKENZA 160MG
- Store below 30C, protect from moisture and light
- Tablets
- Enzalutamide
- Metastatic castration-resistant prostate cancer (mCRPC)
- India
- Enzalutamide 160mg
- 24 months from manufacturing
- Oral
- Hormone Antagonist (Androgen Receptor Inhibitor)
- White to off-white
- To be used under medical supervision
- Capsule-shaped
- Yes
- Treatment of prostate cancer in men
- Mylan
MAKENZA 160MG Trade Information
- 1000 Number Per Week
- 2 Days
- No
- Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
- All India
Product Description
- Active Ingredient: Enzalutamide (160 mg strength)
- Manufacturer/Marketer: Biomak Laboratories Pvt Ltd
- Mechanism of Action: Enzalutamide is an androgen receptor inhibitor (blocker). It works by blocking testosterone (a male hormone) from reaching prostate cancer cells, which slows the cancer's growth or causes it to shrink.
- Form: Tablet or Capsule, for oral consumption.
Uses
Makenza 160 mg is used to treat prostate cancer, including metastatic castration-resistant prostate cancer (mCRPC), non-metastatic castration-resistant prostate cancer (nmCRPC), and hormone-sensitive metastatic prostate cancer (in combination with ADT).
Important Safety Information
- Makenza is a prescription drug for men only and requires medical guidance.
- Men using Makenza must use effective contraception during treatment and for three months afterward due to potential risks to an unborn baby. It is not for women, especially if pregnant or breastfeeding.
- Common side effects include fatigue, back and joint pain, headache, high blood pressure, and sleep difficulties. Seizures are a rare but possible side effect.
Always consult a healthcare professional for complete information and guidance regarding this medication.
Mechanism of Action: Advanced Prostate Cancer Treatment
MAKENZA 160MG works by acting as an androgen receptor inhibitor. This blocks male hormones (androgens) from fueling the growth of cancer cells in men with advanced prostate cancer. Its mechanism helps slow the progression of metastatic castration-resistant prostate cancer, thus offering effective disease control when other treatments may be inadequate.
Administration and Dosage Guidelines
Take MAKENZA 160MG orally, as prescribed by your doctor. Each tablet should be swallowed whole with water, without crushing or chewing, for optimal absorption. Adherence to the prescribed dosage is essential. Avoid self-adjusting the dose or frequency and always consult your healthcare provider about any concerns relating to administration.
Safe Storage and Packaging
This medication comes in a robust, protective blister strip with 28 tablets per box. Store MAKENZA 160MG below 30C, away from moisture and direct light to maintain its potency for up to 24 months from manufacturing. Proper storage ensures stability and effectiveness throughout the shelf life.
FAQ's of MAKENZA 160MG:
Q: How should MAKENZA 160MG be administered for optimal effectiveness?
A: MAKENZA 160MG should be taken orally as prescribed by your doctor. Swallow each tablet whole with a glass of water, without crushing or chewing the tablet. Follow your physician's instructions strictly for the best therapeutic outcomes.Q: What is the main benefit of using MAKENZA 160MG in prostate cancer treatment?
A: The primary benefit of MAKENZA 160MG is that it helps manage and slow the progression of metastatic castration-resistant prostate cancer (mCRPC) by blocking androgens, thus improving disease control in advanced stages.Q: When is MAKENZA 160MG prescribed for prostate cancer patients?
A: MAKENZA 160MG is prescribed for adult male patients diagnosed with metastatic castration-resistant prostate cancer (mCRPC), usually when the cancer no longer responds to traditional hormone therapy.Q: Where should MAKENZA 160MG be stored at home?
A: Store MAKENZA 160MG below 30C, in a dry place protected from moisture and direct light. Keep the tablets in their original blister packaging inside the box to maintain stability and efficacy.Q: What precautions should be observed while using MAKENZA 160MG?
A: MAKENZA 160MG should only be used under strict medical supervision. It is not suitable for children or women, and self-medication is unsafe. Always use the medication as prescribed and report any side effects to your healthcare provider.Q: Who is MAKENZA 160MG suitable for?
A: MAKENZA 160MG is suitable for adult men specifically undergoing treatment for advanced prostate cancer (mCRPC). It is a prescription-only medication and should not be used by individuals without a confirmed medical need.Q: How long can a box of MAKENZA 160MG tablets be used from the manufacturing date?
A: Each box of MAKENZA 160MG can be used within 24 months from the manufacturing date, provided it is stored as instructed below 30C and protected from moisture and direct light.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMSMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
